Owens & Minor is a global healthcare logistics company that specializes in the distribution of medical supplies and products to hospitals, healthcare providers, and other organizations within the healthcare industry
The company provides a range of services, including inventory management, supply chain solutions, and the development of customized healthcare products, ensuring that healthcare providers have timely access to the essential medical items needed to deliver quality patient care. By leveraging technology and comprehensive logistics capabilities, Owens & Minor aims to enhance the efficiency of healthcare operations and improve overall patient outcomes.
Owens & Minor Q3 2024 highlights include a 5% sales increase to $2.72 billion, adjusted EPS of $0.42, and Patient Direct revenue growth led by diabetes and sleep supplies.
Owens & Minor, Inc. (NYSEOMI) plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange.
Owens & Minor, Inc. (NYSEOMI), announced today that Mr. Jonathan Leon has been named Executive Vice President, Chief Financial Officer, effective immediately. Leon will maintain his corporate treasurer responsibilities while a search for his successor is underway. Mr. Leon has been with the Company since 2017, most recently serving as Interim Chief Financial Officer and Corporate Treasurer since June 2024. He will report directly to Mr. Edward Pesicka, President and Chief Executive Officer of Owens & Minor.
Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers.
Owens & Minor, Inc. today announced a new partnership with Google Cloud that combines Owens & Minor’s deep expertise in optimizing the healthcare supply chain with Google Cloud’s Vertex AI platform to help drive meaningful enhancements for QSight®, an industry-leading cloud-based clinical inventory management system from Owens & Minor. By partnering with Google Cloud, Owens & Minor will strengthen QSight’s existing inventory management capabilities while laying the foundation for future platform and service innovations with the potential to dramatically improve the QSight customer experience.
Owens & Minor, Inc. (NYSEOMI), announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Jon Leon, Corporate Treasurer and interim Chief Financial Officer, will participate in a fireside chat at 1:25 p.m. Eastern Daylight Time on Tuesday, September 10, 2024 at Baird’s Global Healthcare Conference in New York City. Owens & Minor is also hosting one-on-one meetings with investors at the conference.
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Helen of Troy Limited (NASDAQHELE), Owens & Minor, Inc. NYSE: OMINYSEOMI)(NASDAQ: IRENNASDAQIREN, and DexCom, Inc. (NASDAQ: DXCMNASDAQ). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Helen of Troy Limited (NASDAQHELE), Owens & Minor, Inc. NYSE: OMINYSEOMI)(NYSE: CRMNYSECRM, and Phreesia, Inc. (NYSE: PHRNYSE). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Owens & Minor reported Q2 2024 adjusted EPS of $0.36, beating consensus. Sales rose to $2.671 billion, driven by growth in diabetes and sleep supplies. The company reaffirms 2024 revenue guidance of $10.5 billion-$10.9 billion and expects adjusted EPS of $1.40-$1.70.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. (“Owens & Minor” or “the Company”) (NYSEOMI) for violations of the securities laws.
NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Helen of Troy Limited (NASDAQHELE), Owens & Minor, Inc. NYSE: OMINYSEOMI)(NYSE: CRMNYSECRM, and Five Below, Inc. (NASDAQ: FIVENASDAQ). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Owens & Minor is set to acquire Rotech Healthcare for $1.36 billion, enhancing its Patient Direct segment and aiming for $5 billion in revenue by 2028. The deal includes anticipated tax benefits and significant synergy opportunities.
Owens & Minor, Inc. (NYSEOMI) today announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaffirmed its outlook for the full year 2024 as noted below in advance of its second quarter 2024 earnings announcement and conference call.
Owens & Minor, Inc. (“Owens & Minor”) (NYSEOMI), today announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. (“Rotech”), a privately held home based care business headquartered in Orlando, Florida, for $1.36 billion in cash. Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion, which represents approximately a 6.3x multiple of LTM EBITDA, excluding synergies.
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Helen of Troy Limited (NASDAQHELE), Target Hospitality Corp. NASDAQ: THNASDAQTH)(NYSE: OMINYSEOMI, and Salesforce, Inc. (NYSE: CRMNYSE). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
